Options Traders Betting That Target’s Stock Will Fall This Much By September Expiration

Target Corporation (NYSE: TGT) reported its second-quarter financial results, before the opening bell on Aug. 16.

Target Corporation (NYSE:TGT) reported its second-quarter financial results, before the opening bell on Aug. 16.

On CNBC’s “Options Action,”  Mike Khouw of Optimize Advisors said Target traded at 5x its average daily put volume on Tuesday and options markets are implying a move of around 7% post the release of quarterly earnings.

Don’t forget to check out our premarket coverage here

There was a buyer of 1,200 of the September 120-puts at an average price of $4.80 per contract, Khouw mentioned.

Trader sees Target’s stock falling at least 5% by September expiration.

The company to post quarterly earnings at $1.80 per share, up sharply from year-ago earnings of 39 cents per share. The company’s revenue came in at $24.77 billion, compared to $26.04 billion in the year-ago period.

Price Action: Target shares fell 2.6% to close at $125.05 on Tuesday, but added 6.6% in Wednesday’s premarket trading session.

Check This Out: TJX, Mercury Systems And 3 Stocks To Watch Heading Into Wednesday

Total
0
Shares
Related Posts
Read More

Hoth Therapeutics Announces Expansion Of FDA Cleared First-In-Human Clinical Trial For Cancer Patients Of HT-001 At University Of Miami For The Treatment Of Skin Toxicities Associated With EGFRi Treatments

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it has received approval from the University of Miami to enroll patients for its first in human clinical

HOTH